GleamWall
中文EN

ZBH ZIMMER BIOMET HOLDINGS, INC.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1136869 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY7.0%
TTM net income YoY-4.7%
TTM EPS YoY-1.7%
Revenue 3-yr CAGR5.6%
Net income 3-yr CAGR17.4%

Margins

Gross margin69.7%
Operating margin13.6%
Net margin9.0%
FCF margin19.2%
EBITDA margin26.5%

Returns

ROE6.0%
ROA3.3%
ROIC (approx.)5.1%
Asset turnover0.36x

Leverage & solvency

Liabilities / assets45.9%
Debt / equity0.59x
Current ratio1.46x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.46x
Accruals ratio-4.8%
Payout ratio24.3%
Capex / revenue2.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$8.23B$7.68B
Cost of revenue$2.49B$2.19B
Gross profit$5.74B$5.49B
R&D expense$458.50M$437.40M
SG&A expense$3.26B$2.93B
Operating income$1.10B$1.29B
Pretax income$830.80M$1.04B
Income tax$125.70M$131.40M
Net income$705.10M$903.80M
EBITDA$2.19B$2.28B
EPS (basic)3.564.45
EPS (diluted)3.554.43
Dividends declared per share0.960.96
Weighted avg. shares (diluted)198.70M203.90M
Banking
Net interest income-$292.80M-$218.00M
Balance sheet
Cash & equivalents$591.90M$525.50M
Receivables$1.70B$1.48B
Inventory$2.29B$2.24B
Current assets$5.12B$4.67B
PP&E, net$2.21B$2.05B
Goodwill$9.95B$8.95B
Intangibles$4.72B$4.60B
Total assets$23.09B$21.37B
Current liabilities$2.58B$2.45B
Short-term debt$587.10M$863.00M
Long-term debt$6.93B$5.34B
Total debt$7.52B$6.20B
Total liabilities$10.39B$8.89B
Shareholders' equity$12.70B$12.47B
Net debt$6.93B$5.68B
Cash flow statement
Operating cash flow$1.70B$1.50B
Capital expenditure$224.50M$203.80M
Free cash flow$1.47B$1.30B
Investing cash flow-$1.98B-$888.10M
Financing cash flow$326.00M-$484.50M
Depreciation & amortization$1.09B$996.30M
Stock-based compensation$90.20M$101.00M
Dividends paid$190.30M$196.00M
Share buybacks$487.00M$868.00M

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.